ChromoTek Vimentin-Label Atto488
anti-vimentin VHH/ Nanobody conjugated to the fluorophore ATTO488 for IF, & microscopy
Cat no : vba488
Synonyms
Validation Data Gallery
Product Information
anti-vimentin VHH/ Nanobody conjugated to the fluorophore ATTO488 for IF, & microscopy
Description | Vimentin-Label specifically binds to the Vimentin intermediate filament protein. Due to its small size, the Vimentin-Labelenables higher image quality in epifluorescence, confocal, and super-resolution microscopy:
• Specific probe for direct immunostaining of Vimentin filaments • Higher image resolution • Less than 4 nm epitope-label displacement minimizes linkage error • Superior accessibility and labeling of epitopes in crowded cellular/organelle environments • Improved target binding due to an avidity effect from the bivalent form of Vimentin-Label |
Applications | Monoclonal |
Host | Alpaca |
Specificity/Target | Vimentin-Label specifically binds to the vimentin intermediate filament protein. Validated on canine MDCK cells, rodent BHK cells and on human A549 cells upon stimulation with TGFβ. |
Conjugate | ATTO 488 |
Physical State | Liquid |
Suggested Dilution | IF/ICC: 1:200 – 1:400 |
Type | Nanobody |
Class | Recombinant |
RRID | AB_2631392 |
Storage Buffer | 1x PBS, 0.09% sodium azide. |
Storage Condition | Shipped at ambient temperature. Upon receipt store at 4°C. Do not freeze. Protect from light. |
Note | This product is for research use only, not for diagnostic or therapeutic use |
Documentation
SDS |
---|
SDS Vimentin-Label ATTO488 (PDF) |
Protocol |
---|
Protocol Vimentin-Label ATTO488 (PDF) |
Brochure |
---|
Chromotek nanobodies brochure (PDF) |
Publications
Application | Title |
---|---|
Nat Neurosci Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull-meninges connections. | |
Light Sci Appl Repeated photoporation with graphene quantum dots enables homogeneous labeling of live cells with extrinsic markers for fluorescence microscopy. | |
bioRxiv Genetic removal of Nlrp3 protects against sporadic and R345W Efemp1-induced basal laminar deposit formation |